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KA]aaKIN/KININOGN activation is an important Intra-pancreatic release of
pathophysiological event in acute pancreatitis,
leading to microcirculatory changes within the bradykinin durin9 the course
gland. Hitherto, only indirect measurements of experimental pancreatitis in rat
pancreatic bradykinin formation have been per-
formed, monitoring the peptide in the circulation
and in the peritoneal exudate. In the present
study, intra-pancreatic bradykinin release was P. J6nssoncA and K. Ohlsson
assessed using microdialysis during experimental
acute pancreatitis in rat. In mild, oedematous
pancreatitis, induced by caerulein hyperstimula- Department of Surgical Pathophysiology, University tion, the levels of bradykinin within the gland
were not elevated compared with those of control Hospital MAS, Lund University, Maim6, Sweden
rats. However, in necrotic pancreatitis, induced
by retrograde injection of taurocholate into the
pancreatic duct, significantly elevated levels of CACorresponding Author
intraglandular bradykinin were seen. Several rats
in this group died whilst in a state of circulatory
shock.
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Introduction The purpose of this work was to elucidate
whether the release of bradykinin in the pancre-
Release of bradykinin has been demonstrated atic gland is more profuse during taurocholate-
during acute pancreatitis and is proposed to con- induced pancreatitis in rat, often leading to
tribute to the development of hypotension and shock, than during caerulein-induced pancreatitis.
shock.’2 Bradykinin is one of the most potent
vasodilators in man, causing loss of intravascular Materials and Methods fluid by increasing the capillary permeability. It
may also generate severe pain. Bradykinin is Animal experiments: Adult Wistar rats of both
formed in blood through limited proteolysis of sexes, weighing 205-260g were obtained from
the kininogens by activated plasma kallikrein. M611egaard Avelslab A/S (Skensved, Denmark).
Kallidin (lysyl-bradykinin) is released from The animals were deprived of food but not of
kininogens by glandular kallikrein and may be water for 18h before the experiments. Anaes-
converted to bradykinin by amino peptidases in thesia was maintained by repeated injections of
plasma.
4 In pancreatitis, trypsinogen is activated mebumal (barbital) into the peritoneal cavity.
to trypsin in the pancreatic gland.5’6 Trypsin may The body temperature was continuously moni-
then activate the pro-kallikreins and also directly tored and adjusted if necessary. A polyethylene
release bradykinin from kininogen.
2 catheter (PE 90) was introduced into a femoral
Direct measurement of activated bradykinin in vein. All animals received saline intravenously at
the circulation is difficult due to the great capa- 4 ml/h. The pancreas was exposed through a
city of blood to both generate and degrade this mildline incision. Rats were randomly segregated
peptide.7’8 The kinins are rapidly inactivated by into three groups; caerulein-induced pancreatitis
carboxypeptidases (kinase I and II) and have an (n 6), taurocholate-induced pancreatitis
estimated half-life of about 20 s in the human cir- (n 8) and controls (n 6).
culation.9 The plasma levels of bradykinin repor- Caerulein pancreatitis was induced by intrave-
ted for man vary considerably when measured by nous infiasion of caerulein (Sigma, St Louis, MO,
10 11 bio-assay and radioimmunoassay. USA), 10 I,tg/kg/h for 6 h.
The microdialysis technique
12-15 offers the Taurocholate pancreatitis was induced by ret-
possibility of studying the bradykinin release rograde injection of sodium taurocholate (Sigma,
directly in the interstitial fluid of the pancreas, by St Louis, MO, USA) into the pancreatic duct
selecting probe membranes with a permeability system. The common bile and pancreatic duct
allowing the passage of bradykinin (MW , 1 was cannulated trans-duodenally and the duct
kDa) but not of the kinases (MW 45 kDa). was temporarily occluded proximal of the con-
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necting pancreatic ductuli by application of a vas- Statistics: Results are expressed as means
cular clamp. Taurocholate diluted in saline, 0.8 (_S.E.M.). The Mann-Whitney U-test was used
ml 4% (w/v), was injected into the common duct to determine possible differences between
for 90 s and the clamp was removed, groups of rats with pancreatitis and the control
All three groups were subjected to micro- group. A p value less than 0.05 was considered
dialysis of the extracellular fluid of the pancreatic sigfiificant.
gland. A 10 mm long probe, with a diameter of
0.5 mm, was introduced into the central part of Results the pancreatic gland. The polycarbonate mem-
brane had a molecular weight cut-off of less than All animals in the control group and in the
20 kDa. A micro-injection pump (CMA/100) and caerulein group sueeived the observation period
a micro-sampler (CMA/200) were used (CMA/ of 6 h, while three of the animals in the tauro-
Microdialysis AB, Stockholm, Sweden). Ringer’s cholate group died. At autopsy, a severe inflam-
solution (Baxter, Norway) was used as perfusion matory reaction was seen in the pancreatic gland
fluid at a flow rate of 5 l.tl/min and 30 min frac- in the taurocholate group with haemorrhage,
tions were collected at +4C in the fraction col- oedema and necrotic areas, while in the caerulein
lector and stored at -70C until analysed, group, only modest oedema was seen, without
Microdialysis was started when pancreatitis was bleeding or obvious necrosis. The microdialysis
induced, procedure did not cause any significant inflam-
Samples of venous blood were drawn at 0 h, matory reaction. The microscopic appearance of
2h and 6 h into EDTA-containing tubes. After the pancreas was essentially normal after 6 h of
centrifugation, the plasma samples were stored at microdialysis (Fig. 1).
-20C until analysed. The concentration of bradykinin in the micro-
All animals surviving the observation period dialysate from taurocholate rats showed a rapid
were killed with an overdose of mebumal. The
study was approved by the ethics committee of
tund University.
Assays: Bradykinin was measured using a radio-
immunoassay technique described previously.
125 8 Briefly, I-tyr-bradykinin was obtained from
NEN (Du Pont, Wilmington, DE, USA) and used
as tracer. The specific activity was 1 800 l.tCi/l.tg.
The tracer was reconstituted with distilled water,
diluted to 50 t.tCi/ml and kept at-70C. The RIA
buffer included barbital 0.075 M and bovine
serum albumin 0.2% at pH 8.6. A 0.2 ml sample
or standard was incubated with tracer, 0.05 ml
(30000 cpm), and antibody solution, 0.05 ml (1/
2500) in the RIA buffer. The reaction mixture
was incubated at +4C for 18h. For the separa-
tion, 1 ml of the buffer containing 0.15% char-
coal and 0.015% dextran P70 was added. After
centrifugation at 2 500 x g for 15 min, 1 ml of
the supernatant was transferred to a disposable
plastic tube and counted for 20 min in a gamma
scintillation counter. The sensitivity of the RIA,
defined as the lowest standard producing a sig-
nifican displacement of labelled antigen, was 10
lg/1. With the bradykinin cross-reaction set at
100%, the antiserum cross-reacted with kallidin to
97%, with metionyl-lysyl bradykinin to 42% and
with des-arginine-bradykinin to 82%. Amylase was
measured using the Phadebas Amylase Test
(Pharmacia Diagnostica AB, Uppsala, Sweden)
and a2-acute phase protein (2-aP) was meas- FIG. 1. Rat pancreas stained in haematoxylin-eosin after 6h of
microdialysis (x 30 and x 125). Apart from slight interlobular ured in the blood samples using electro- oedema, the microscopic appearance of acini and Iobuli was
immunoassay.
16 normal. No infiltration of inflammatory cells was seen.
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FIG. 2. Dialysate levels, mean (_S.E.M.), of immunoreactive
bradykinin during taurocholate- (.) and caerulein- (t)) induced
pancreatitis in rats, compared with controls ((C)). *p < 0.05 and
**p< 0.01 indicate differences between control and tauro-
cholate rats.
increase, with a mean maximum value of 3.5 l.tg/1
1 hour after induction of the pancreatitis (Fig. 2).
The level was significantly increased for about 4 h
compared with the control rats. The increase in
bradykinin concentration in the dialysates from
the animals with caerulein-induced pancreatitis
was modest and did not differ significantly from
that of the control group.
The caerulein group showed the most pro-
nounced increase in amylase levels with a mean
value of 450 t.tcat/1 after 6 h. In comparison, the
mean value of the taurocholate group was 180
I.tcat/1 and the control group 70 t.tcat/1 after 6 h
(Fig. 3).
The plasma concentration of t2-AP increased
in all three groups, but the most pronounced
increase was seen in the taurocholate group
(Fig. 4).
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FIG. 3. Plasma levels, mean (___ S.E.M.), of amylase during tauro-
cholate- (,) and caerulein- (I)) induced pancreatitis in rats and
amylase levels in the control group (O). *p<0.05 and
**p < 0.01 indicate differences between control rats and rats
with pancreatitis.
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FIG. 4. Plasma levels, mean (JrS.E.M.), of 2-AP in rats during
taurocholate-() and caerulein- (O) induced pancreatitis and in
control animals ((C)). *p < 0.05 and **p < 0.01 indicate differ-
ences between control rats and rats with pancreatitis.
Discussion
The activation of kininogen is an important
pathophysiological event in acute pancreatitis.
Bradykinin antagonists may improve the outcome
in experimental pancreatitis by reducing pancrea-
tic oedema and hypotension.7’8 Measurements
of activated bradykinin have been performed in
blood and peritoneal exudate, but not where the
inflammatory process beginsin the pancreas.
We have earlier adapted the microdialysis tech-
nique for the exocrine pancreas.’4 In this study
we utilized the system for the evaluation of intra-
pancreatic bradykinin release during experi-
mental pancreatitis. Introduction of the micro-
dialysis probe into the pancreatic gland caused
only a minor trauma to the tissue, as judged
from the low initial bradykinin level in the dialy-
sate. Furthermore, the microscopic appearance
of the pancreatic tissue was normal after 6 h of
microdialysis. Microdialysis has already been used
to measure bradykinin in clinical studies, not
concerned with pancreas, but after oral
surgery.15’19 The membrane of the probe does
not induce bradykinin formation.5
In this study, we used two different models of
experimental pancreatitis. Hyperstimulation of
the pancreatic gland with caerulein, a synthetic
cholecystokinin analogue, produces a mild oede-
matous form of pancreatitis in 1-2 h which later
20 21 restitutes. This form of pancreatitis did not
cause release of bradykinin into the interstitium
of the pancreatic gland. Increased levels of
bradykinin have recently been demonstrated in
venous blood from rats with caerulein-induced
pancreatitis.
22 Differences in methodology andIntra-pancreatic bradykinin release
types of test samples prelude detailed compar-
isons, but our results indicate that the bradykinin
release in this type of pancreatitis is rather low,
at least in comparison with the taurocholate
model. On the other hand, the highly elevated
serum amylase levels reflect hyperstimulation of
the pancreas.
Injection of taurocholate into the pancreatic
duct induces severe pancreatitis, as evidenced by
the autopsy findings and the mortality in this
group during the observation period. This form
of experimental pancreatitis is connected with
grave microcirculatory disturbances in the pan-
creatic land and, eventually, hypotension and
shock.23, 4 The severity of the disease is also
illustrated by the pronounced release of bradyki-
nin within the gland, as evidenced by the high
levels in the dialysate. These results are also in
agreement with earlier, more indirect, findings
indicating that the kinin release in acute pancrea-
titis was localized to the abdominal region, as
illustrated by kininogen consumption in the peri-
toneal exudates.
2 The very rapid acute phase
protein ai-AP showed much higher plasma levels
in the taurocholate group than in the caerulein
group and in the controls, reflecting the more
severe inflammation in the taurocholate group.
In conclusion, microdialysis appears to offer a
convenient method of monitoring the intra-pan-
creatic release of bradykinin and should also be
applicable to the study of other peptides. Severe
pancreatitis appears to be accompanied by an
extensive release of bradykinin within the gland,
probably contributing to the oedema and tissue
damage seen in this disease.
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